Find a Clinical Trial
Is a clinical trial right for you? Search our database to find studies for which you may be eligible.
Phase 1b Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Repeated Doses of DB-020 in Patients Receiving Cisplatin
A Randomized, Multicenter, Phase III Trial of Tacrolimus/Methotrexate versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation
A Phase IIa, Placebo-Controlled, Randomized Study of Daily Obeticholic Acid OCA to Reduce Intestinal Polyp Burden in Familial Adenomatous Polyposis FAP
A Phase IIb Clinical Trial of the Multitargeted Recombinant Adenovirus 5 CEA/MUC1/Brachyury Vaccines Tri-Ad5 and IL-15 Superagonist N-803 in Lynch syndrome
Advancing Tobacco Use Treatment for African American Smokers
Study Type: Prevention
Phase: IV
NCTID: NCT02360631
Principal Investigator:
Lisa Cox
Phase IIB pre-surgical trial of oral tamoxifen TAM versus transdermal 4-hydroxytamoxifen 4-OHT in women with DCIS of the breast
Effects of Tirzepatide on Blood, Imaging and Breast Tissue Biomarkers in Women with Obesity and Other Risk Factors for Breast Cancer
Study Type: Prevention
Phase: Feasibility/Pilot
NCTID: NCT06485089
Principal Investigator:
Carol Fabian
Pharmacologic Reversal of Ventricular Remodeling in Childhood Cancer Survivors at Risk for Heart Failure PREVENT-HF: A Phase 2b Randomized Placebo-Controlled Carvedilol Trial
Study Type: Prevention
Phase: II
NCTID: NCT02717507
Principal Investigator:
Keith August
Randomized IIB Study of the Effect of Bazedoxifene plus Conjugated Estrogens on Breast Imaging and Tissue Biomarkers in Peri or Post-Menopausal Women at Increased Risk for Development of Breast Cancer
A Phase 3, Randomized, Adaptive Study Comparing the Efficacy and Safety of Defibrotide vs Best Supportive Care in the Prevention of Hepatic Veno-Occlusive Disease in Adult and Pediatric Patients Undergoing Hematopoietic Stem Cell Transplant
Study Type: Prevention
Phase: III
NCTID: NCT02851407
Principal Investigator:
Rakesh Goyal